EyePoint, Inc. Finance Lease, Right-of-Use Asset, Amortization
EyePoint, Inc. (EYPT) reported Finance Lease, Right-of-Use Asset, Amortization of $133.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2023-03-10
- EyePoint, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-12-31 was $32.00K, a 25.58% decline year-over-year.
- EyePoint, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-09-30 was $34.00K, a 26.09% decline year-over-year.
- EyePoint, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-06-30 was $34.00K, a 13.33% increase year-over-year.
- EyePoint, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $34.00K, a 6.25% increase year-over-year.
- EyePoint, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $133.00K, a 11.92% decline from fiscal 2021.
- EyePoint, Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $151.00K, a 190.38% increase from fiscal 2020.
- EyePoint, Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $52.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2022-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $66.00K derived: sum of 2 quarters · filed 2023-03-10 | $100.00K derived: sum of 3 quarters · filed 2023-03-10 | $133.00K 10-K · filed 2023-03-10 |
| 2022-09-30 | $34.00K 10-Q · filed 2022-11-04 | $68.00K derived: sum of 2 quarters · filed 2022-11-04 | $101.00K 10-Q · filed 2022-11-04 | $145.00K derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-06-30 | $34.00K 10-Q · filed 2022-08-05 | $68.00K 10-Q · filed 2022-08-05 | $111.00K derived: sum of 3 quarters · filed 2023-03-10 | $157.00K derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-03-31 | $34.00K 10-Q · filed 2022-05-06 | $77.00K derived: sum of 2 quarters · filed 2023-03-10 | $123.00K derived: sum of 3 quarters · filed 2023-03-10 | $153.00K derived: sum of 4 quarters · filed 2023-03-10 |
| 2021-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $89.00K derived: sum of 2 quarters · filed 2023-03-10 | $119.00K derived: sum of 3 quarters · filed 2023-03-10 | $151.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $46.00K 10-Q · filed 2022-11-04 | $76.00K derived: sum of 2 quarters · filed 2022-11-04 | $108.00K 10-Q · filed 2022-11-04 | $121.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $30.00K 10-Q · filed 2022-08-05 | $62.00K 10-Q · filed 2022-08-05 | $75.00K derived: sum of 3 quarters · filed 2022-08-05 | $88.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $32.00K 10-Q · filed 2021-05-05 | $45.00K derived: sum of 2 quarters · filed 2022-03-14 | $58.00K derived: sum of 3 quarters · filed 2022-03-14 | $71.00K derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $26.00K derived: sum of 2 quarters · filed 2022-03-14 | $39.00K derived: sum of 3 quarters · filed 2022-03-14 | $52.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $13.00K 10-Q · filed 2021-11-05 | $26.00K derived: sum of 2 quarters · filed 2021-11-05 | $39.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $13.00K 10-Q · filed 2021-08-06 | $27.00K 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $14.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |